RCE News: Recce Pharmaceuticals Appoints Philip Sutton, Ph.D., as Vice President of Translational Sciences - 12th Jul 2022, 10:00pm

annb0t

Top 20
Recce Pharmaceuticals

– Dr. Sutton to help advance Recce’s portfolio of infectious disease programs focused on significant unmet medical needs –

SYDNEY Australia, July 12, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synthetic anti-infectives, is pleased to announce the appointment of Philip Sutton, Ph.D., as Vice President of Translational Sciences.

“Dr. Sutton joins us at an exciting time as ou...

>>> Read more: Recce Pharmaceuticals Appoints Philip Sutton, Ph.D., as Vice President of Translational Sciences
 
Top Bottom